Home / news / Takeda Acquires Ariad Pharmaceuticals in $5.2 Billion Deal

Takeda Acquires Ariad Pharmaceuticals in $5.2 Billion Deal

collected by :Rechard Bernard

follow the latest news of” market news” from different sites to most famous technicals / by 2017-01-10 at 8:10

As it stated in

Ariad Pharmaceuticals to be acquired by Takeda for $5.2 billion

Ariad Pharmaceuticals to be acquired by Takeda for $5.2 billion*/

– Takeda’s transaction will give the Japanese drug giant rights to Iclusig, the approved Ariad drug to treat chronic myeloid leukemia.Ariad Pharmaceuticals Inc. on Monday accepted a $5.2 billion takeover offer from Japan’s Takeda Pharmaceuticals Inc., making the Cambridge company the latest Massachusetts biotech to be gobbled up by a global drug company seeking to strengthen its product line.The 26-year-old Ariad has a blood cancer drug on the market and is seeking US approval for a lung cancer treatment.
.

read more from here

Ariad Pharmaceuticals (Nasdaq: ARIA) Agrees to $5.2 Billion Buy-out – Stock News Union

Ariad Pharmaceuticals (Nasdaq: ARIA) Agrees to $5.2 Billion Buy-out – Stock News Union*/

– Ariad Pharmaceuticals, Inc. – Nasdaq: ARIATakeda Pharmaceutical Company Inc. has agreed to purchase Cambridge, MA-based Ariad Pharmaceuticals for $24 per share.Ariad’s shares, traded on the Nasdaq under ticker ARIA, closed Friday at $13.74 and shot up to an intraday high of $23.81.The $5.2 Billion deal represents a 75% premium over the Friday closing price.
.

read more from here

Takeda Acquires Ariad Pharmaceuticals in $5.2 Billion Deal

Takeda Acquires Ariad Pharmaceuticals in $5.2 Billion Deal*/


.

read more from here

read more
visit us
news

About finance market

Avatar for finance market

Check Also

U.S. Government Spends Your Tax Dollar As tax day approaches picture-12359-310x165

U.S. Government Spends Your Tax Dollar As tax day approaches

The so-called Tax March falls on April 15, the nation’s traditional deadline for submitting tax …